News
Upadacitinib curbed UC symptoms from Day 1 in study
“Clinicians treating IBD patients should take the time to response into consideration, because it leads to rapid improvement in quality of life...
News
ADA issues 2023 ‘Standards of Care’ for diabetes: Focus on tight BP, lipids
The new 2023 American Diabetes Association Standards of Care address management of diabetes and its complications, as well as social determinants...
News
As COVID treatments dwindle, are new ones waiting in the wings?
Bebtelovimab couldn’t neutralize the Omicron subvariants BQ.1 and BQ.1.1.
Opinion
Does paying people to lose weight work?
Thousands of genes and dozens of hormones are involved in our individual levels of hunger, cravings, and fullness.
News
Low-carb, high-fat, calorie-unrestricted diet improves type 2 diabetes
The benefits of the diet were seen regardless of a person’s calorie intake.
News
Direct-acting antivirals tied to better outcomes in chronic Hep C
Researchers saw a significant reduction in all-cause mortality over a decade with direct-acting antivirals compared with no treatment.
News
Cardiologist sues hospital, claims he was fired in retaliation
Lawsuit alleges that the defendants “placed profit above all else.”
News
Three antiseizure medications join list for newborn risks
A Scandinavian study of 4.5 million births adds carbamazepine, oxcarbazepine, and topiramate to list of antiseizure drugs linked to low birth...
News
Following the CHEST Foundation in 2022
As 2022 draws to a close, look back at the progress made over the past 12 months.
News
‘Exciting’ responsiveness to talquetamab for r/r MM
The novel antibody talquetamab may buy time for patients with multiple myeloma (MM) for whom few other options remain.